MetLife, Inc.
MET
$69.13
$1.161.71%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 35.62% | -1.46% | |||
| Total Other Revenue | 662.79% | 118.22% | |||
| Total Revenue | 37.17% | 0.13% | |||
| Cost of Revenue | 49.41% | -3.10% | |||
| Gross Profit | 1.71% | 10.85% | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 5.59% | 6.16% | |||
| Total Operating Expenses | 40.62% | -1.37% | |||
| Operating Income | -8.63% | 25.59% | |||
| Income Before Tax | -7.69% | 23.47% | |||
| Income Tax Expenses | -2.27% | 25.71% | |||
| Earnings from Continuing Operations | -9.53% | 22.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -16.67% | 0.00% | |||
| Net Income | -9.71% | 22.91% | |||
| EBIT | -8.63% | 25.59% | |||
| EBITDA | 42.58% | 25.08% | |||
| EPS Basic | -3.93% | 18.27% | |||
| Normalized Basic EPS | -6.95% | 24.84% | |||
| EPS Diluted | -4.11% | 17.49% | |||
| Normalized Diluted EPS | -6.92% | 24.80% | |||
| Average Basic Shares Outstanding | -0.99% | -0.91% | |||
| Average Diluted Shares Outstanding | -1.03% | -0.87% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.01% | -0.13% | |||